Speaker illustration

Doctor Takanori Watanabe

Kyushu University Hospital, Fukuoka (Japan)

Hyperuricemia impaired nitric oxide bioavailablity and deteriorated pulmonary arterial hypertension via a uric acid transporter, URATv1 in xanthine oxidoreductase (XOR)-independent manner

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Hypertension, Pulmonary Hypertension

Session: Pulmonary Hypertension: Targets for Therapies


This platform is supported by

logo Novo Nordisk